Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gamma Scintigraphy of Ibuprofen Formulations
NCT03497715Phase 1Terminated
- Sponsor
- Reckitt
- Start
- Apr 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ibuprofen in pain, inflammation and fever (4 arms), sponsored by Reckitt. Primary endpoint: Radioactive counts at 3 hours. Started Apr 2015; status: terminated.
02
Drugs
ibuprofen
03
Conditions
paininflammationfever
Beyond the preview
Go deeper on NCT03497715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03497715.